文献速递头颈外科

放射性碘治疗通过降低非肿瘤原因死亡风险改善甲状腺嗜酸细胞癌的总生存:4641例患者的竞争风险分析

Radioactive iodine therapy improves overall survival outcome in oncocytic carcinoma of the thyroid by reducing death risks from noncancer causes: A competing risk analysis of 4641 patients.
PubMed 文献 · Head Neck · 2024-04-04

基于SEER数据库2000至2018年4641例甲状腺嗜酸细胞癌(OCA)患者,采用Cox比例风险回归和竞争风险分析。结果显示肿瘤大小、SEER分期、原发手术和颈部淋巴结清扫是肿瘤特异性生存的预后因素;年龄超过55岁显著增加非OCA死亡风险;RAI治疗可通过降低非肿瘤死亡风险改善生存。

要点

  • 年龄超过55岁显著增加非OCA死亡风险。
  • 甲状腺全切、RAI治疗和全身治疗可改善非OCA生存。
  • 颈淋巴结清扫不建议用于OCA,因转移淋巴结比率约3%。

核心结论

  • RAI治疗可通过降低非肿瘤死亡风险改善OCA患者的生存。

研究设计与样本

  • 从SEER数据库识别2000至2018年4641例OCA患者,采用Cox比例风险回归和竞争风险分析。

主要发现

  • 肿瘤大小、SEER分期、原发手术和颈部淋巴结清扫是肿瘤特异性生存的预后因素。
  • 竞争风险分析显示年龄超过55岁大幅增加非OCA死亡风险。
  • 转移淋巴结比率低,约3%。

关键数值与推荐

  • 年龄超过55岁的OCA患者应推荐改善非OCA生存的治疗,包括甲状腺全切、RAI治疗和全身治疗。
  • OCA患者不建议推荐颈淋巴结清扫,因转移淋巴结比率约3%。

临床怎么用

  • 年龄超过55岁的OCA患者应推荐甲状腺全切、RAI治疗和全身治疗以改善非OCA生存。
  • OCA患者不建议推荐颈淋巴结清扫。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oncocytic carcinoma of the thyroid (OCA) is an independent type of thyroid cancer. Radioactive iodine (RAI) therapy was frequently administered to OCA patients, but its contribution to improving survival is indefinite. METHODS: 4641 OCA patients from 2000 to 2018 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazard regression and competing risk analysis were applied. RESULTS: Tumor size, SEER stage, primary surgery, and neck dissection were prognostic factors for cancer-specific survival. The results of competing risk analysis demonstrated that age over 55 years dramatically increased non-OCA death risks. Treatments that improve non-OCA survival (including total thyroidectomy, RAI therapy, and systemic therapy) should be recommended in OCA patients older than 55 years of age. Neck lymphadenectomy should not be recommended for OCA, since the metastatic lymph node ratio was low (about 3%). CONCLUSIONS: RAI therapy can improve survival in OCA by reducing noncancer death risks.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Zhang K, Wang X, Wei T, et al. Radioactive iodine therapy improves overall survival outcome in oncocytic carcinoma of the thyroid by reducing death risks from noncancer causes: A competing risk analysis of 4641 patients. Head Neck. 2024. PMID: 38572629. doi:10.1002/hed.27758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。